{"id":"W2900828482","doi":"10.1016/j.drudis.2018.11.011","title":"Advancing nonclinical innovation and safety in pharmaceutical testing","year":2018,"lang":"en","type":"review","venue":"Drug Discovery Today","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian Centre for Policy Alternatives","funders":"National Academy of Sciences; Defense Advanced Research Projects Agency","keywords":"Human use; In silico; Drug discovery; Drug development; Pharmacology; Risk analysis (engineering); Drug; Medicine; Computer science; Biotechnology; Bioinformatics; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00580404,0.001097553,0.001402816,0.003853833,0.0006043467,0.003543088,0.001718583,0.003904853,0.007224855],"category_scores_gemma":[0.005359123,0.0004560017,0.0009197465,0.003154885,0.002586661,0.00491141,0.002329175,0.004730306,0.003553996],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002069863,"about_ca_system_score_gemma":0.005125062,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001393334,"about_ca_topic_score_gemma":0.001662346,"domain_scores_codex":[0.9971847,0.000757219,0.0002909983,0.0003016781,0.00128814,0.0001772118],"domain_scores_gemma":[0.9943168,0.003586006,0.0004909278,0.0002818293,0.001065556,0.0002588632],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003362341,0.00008314418,0.000179361,0.02042987,0.00004759248,0.0002501201,0.0002032506,0.0002641314,0.001775147,0.04095712,0.02868154,0.907095],"study_design_scores_gemma":[0.000005576398,0.00004052027,0.0002032458,0.003930023,0.00002239851,0.0004883808,0.00007555382,0.00004503563,0.0005095307,0.006236135,0.988431,0.00001266645],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000117513,0.9912196,0.0009013509,0.001990834,0.0006567039,0.00002256291,0.00002041216,0.00001981225,0.005051279],"genre_scores_gemma":[0.001521315,0.9937018,0.001159919,0.001302596,0.0005230735,0.00002584951,0.00003953094,0.000007087047,0.00171882],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007224855,"threshold_uncertainty_score":0.03069508,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08038240903818748,"score_gpt":0.4101058111567351,"score_spread":0.3297234021185476,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}